NCT00039910 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00038467 Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00038311 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00038103 Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen Status COMPLETED Phase PHASE2
NCT00037804 Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction Status COMPLETED Phase PHASE1
NCT00037791 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00037219 The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. Status COMPLETED Phase PHASE2
NCT00037206 A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). Status COMPLETED Phase PHASE2/PHASE3
NCT00037180 For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy Status TERMINATED Phase PHASE2
NCT00037050 Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria Status COMPLETED Phase PHASE3
NCT00036270 Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane Status COMPLETED Phase PHASE3
NCT00036218 Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. Status COMPLETED Phase PHASE3
NCT00036205 Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease Status TERMINATED Phase PHASE3
NCT00036140 Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00035854 New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) Status COMPLETED Phase PHASE3
NCT00035425 Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection Status COMPLETED Phase PHASE3
NCT00035347 Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia Status COMPLETED Phase PHASE4
NCT00035269 New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) Status COMPLETED Phase PHASE3
NCT00034957 Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2